Federal Jury Finds California Drug Supplier Guilty of Distribution in Relation to Fatal Fentanyl Overdose of Fairbanks Man
Skip to main content
U.S. flag

An official website of the United States government

Here’s how you know

Dot gov

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Https

Secure .gov websites use HTTPS
A lock ( Lock A locked padlock ) or https:// means you’ve safely connected to the .gov website. Share sensitive information only on official, secure websites.

  • Who We Are
    • About
    • Mission
    • History
    • Divisions
      • Domestic Divisions
      • Foreign Divisions
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • What We Do
    • Forensic Sciences
      • GUARDS
      • Forensic Sciences Policy
      • Forensic Science Organizations
      • Forensic Science Contact
    • Law Enforcement
      • DEA Office of Training
        • Office of Training Programs
      • El Paso Intelligence Center (EPIC)
      • Intelligence
      • Operations
        • Administrative Law Judges
        • DEA Asset Forfeiture
        • Domestic Cannabis Suppression / Eradication Program
        • HIDTA
        • OCDETF
    • Education and Prevention
      • Family Summit
      • Red Ribbon
      • Kiki and the History of Red Ribbon Week
      • Red Ribbon Toolkit - Resources For Your Community
      • DEA’s Family Summit
      • Operation Engage
      • Community Outreach
      • Just Think Twice
      • Campus Drug Prevention
      • Get Smart About Drugs
      • Operation Prevention
    • Drug Information
      • Drug Policy
      • Drug Scheduling
      • The Controlled Substances Act
    • News
      • Alerts
      • Press Releases
      • Most Wanted Fugitives
        • All Fugitives
      • Stories
      • Events
      • Speeches
      • Testimony
    • Campaigns
      • One Pill Can Kill
        • Senior Citizens
        • Partner Toolbox
        • Social Media Campaign
      • DEA National Prescription Drug Take Back Day
  • Careers
    • Special Agent
      • Special Agent FAQs
    • Diversion Investigator
      • Diversion Investigator Job Announcement
    • Intelligence Research Specialist
      • Intelligence Research Specialist Job Announcements
      • Intelligence Research Specialists FAQs
      • Schedule A Hiring Authority: Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
      • How To Claim Veterans' Preference
      • Priority Consideration
      • Benefits
      • Veterans and People With Disabilities
      • Operation Warfighter
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
      • Domestic Arrests
      • Staffing and Budget
    • FOIA
      • About FOIA
      • Contact DEA FOIA
      • Make a Request
      • What Happens After Making a Request
      • Requester Categories
      • Fees Charged
      • Fee Waiver
      • FOIA FAQ
      • FOIA Logs and Reports
      • FOIA Library
      • Additional FOIA Links
      • FOIA Exemptions
      • What Are Exclusions?
      • Privacy Act
      • Privacy Act Exemptions
      • Privacy Impact Assessment and Management Information Systems
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
      • Victim Witness Assistance Program Resources
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Get Updates
  • Scam Alert
  • Full Menu
  • English
  • Español

Main Menu

Explore DEA
  • Who We Are
    • About
    • Mission
    • History
    • Divisions
    • DEA Museum
    • Wall of Honor
    • Contact Us
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Education and Prevention
    • Drug Information
    • News
    • Campaigns
  • Careers
    • Special Agent
    • Diversion Investigator
    • Intelligence Research Specialist
    • Forensic Sciences Careers
    • Professional & Administrative Careers
    • Student & Entry Level Careers
    • Employment Eligibility
    • How to Apply
  • Resources
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Data and Statistics
    • FOIA
    • Publications
    • Media Galleries
    • Victim Witness Assistance Program
  • Submit A Tip

Breadcrumb

  • Home
  • Federal Jury Finds California Drug Supplier Guilty of Distribution in Relation to Fatal Fentanyl Overdose of Fairbanks Man

Federal Jury Finds California Drug Supplier Guilty of Distribution in Relation to Fatal Fentanyl Overdose of Fairbanks Man

April 23, 2024
|
Share Article
|
Download Press Release
For Immediate Release
Contact:
Phone Number: (571) 387-3831

FAIRBANKS, Alaska – A federal jury convicted a California drug dealer late Friday for his connection to the fatal fentanyl overdose of a Fairbanks man.

According to court documents and evidence presented at trial, Junior Gafatasi Tulali, 48, was the original source of fentanyl pills that were sold to a Fairbanks man who died of a fentanyl overdose in October 2020.

Around Oct. 13, 2020, Tulali agreed to sell 500 Oxycodone M30 pills to a dealer in Fairbanks, when in fact, they were counterfeit pills laced with deadly fentanyl. The pills were shipped from California and arrived in Fairbanks on Oct. 17, 2020. The individual who retrieved the shipment distributed the counterfeit pills to several other dealers in the area. On Oct. 26, 2020, the victim purchased two pills from the shipment and was found dead in his home on Oct. 28, 2020. Medical examiners determined cause of death was acute toxic effects of fentanyl.

Evidence presented at trial connected two additional non-fatal fentanyl overdoses to Tulali’s shipment of counterfeit pills. Both of the dealers in Fairbanks who were involved in selling the fentanyl pills to the victim were convicted for their role in this offense in 2022.

“Mr. Tulali’s actions clearly demonstrated the grievous threat that fentanyl traffickers pose to our communities,” said David F. Reames, Special Agent in Charge, DEA Seattle Field Division. “Fentanyl traffickers have caused the deaths of far too many Alaskans and hopefully the work of the Drug Enforcement Administration and our partners in achieving this conviction will slow the deadly fentanyl trade in our community.”

“Fentanyl is poison and has killed too many Alaskans,” said U.S. Attorney S. Lane Tucker. “The successful conviction of Mr. Tulali highlights my office’s vow to prioritize working with law enforcement to keep fentanyl out of our communities and prosecute those who cause irreparable damage by trafficking it to our state from Outside.”

“I am very proud of the role that Fairbanks Police officers played in helping the victims in this case find justice. The impressive collaboration between law enforcement agencies to hold this criminal accountable proves that we will do whatever is necessary to prevent criminal enterprises from gaining a foothold in our community,” said Chief Ron Dupee of the Fairbanks Police Department.

The Drug Enforcement Administration and Fairbanks Police Department, with assistance from the FBI Anchorage Field Office and Alaska State Troopers, investigated the case.

Assistant U.S. Attorneys Carly Vosacek and Alana Weber are prosecuting the case.

###

Download Press Release
###
Fentanyl
US Department of Justice - Drug Enforcement Administration

Drug Enforcement Administration

David F. Reames Special Agent in Charge - Seattle
@DEASeattleDiv
  • Facebook
  • X
  • Email

SAMHSA Behavioral Health Treatment Locator

  • Who We Are
    • About
    • Domestic Divisions
    • Foreign Offices
    • Contact Us
    • DEA Museum
  • What We Do
    • Forensic Sciences
    • Law Enforcement
    • Drug Prevention
    • Diversion Control Division
    • News
  • Careers
    • Special Agent
    • Diversion Investigator
    • Forensic Sciences
    • Intelligence Research Specialist
    • How to Apply
  • Resources
    • Drug Information
    • Employee Assistance Program
    • FOIA
    • Publications
    • Media Galleries
    • VWAP
  • Doing Business
    with the DEA
    • Overview
    • Current Vendors
    • Prospective Vendors
    • Security Clauses
    • Security Forms
    • Small Business Program
    • Vendor Engagement Request
  • Policies
    • Accessibility & Policy
    • Legal Policies & Disclaimers
    • No FEAR Act
    • Privacy Policy
    • U.S. Department of Justice EEO Policy
    • USA.gov
    • Whistleblower Protection
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000 info@dea.gov
Contact the Webmaster